|
KIF18A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9288016456519E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87775999999085E-05 |
| Normal-vs-Stage2 |
7.210400E-02 |
| Normal-vs-Stage3 |
4.189200E-04 |
| Normal-vs-Stage4 |
7.196800E-03 |
| Stage1-vs-Stage2 |
4.330400E-01 |
| Stage1-vs-Stage3 |
3.597300E-03 |
| Stage1-vs-Stage4 |
2.750500E-02 |
| Stage2-vs-Stage3 |
4.195500E-02 |
| Stage2-vs-Stage4 |
1.036580E-01 |
| Stage3-vs-Stage4 |
7.944400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.36160000338859E-08 |
| Normal-vs-AfricanAmerican |
1.355530E-03 |
| Normal-vs-Asian |
1.092790E-01 |
| Caucasian-vs-AfricanAmerican |
8.187000E-01 |
| Caucasian-vs-Asian |
2.386400E-01 |
| AfricanAmerican-vs-Asian |
5.940000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.14890000133283E-08 |
| Normal-vs-Female |
3.78509999998666E-06 |
| Male-vs-Female |
2.720500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.815900E-03 |
| Normal-vs-Extreme_Weight |
1.772130E-04 |
| Normal-vs-Obese |
9.370200E-04 |
| Normal-vs-Extreme_Obese |
2.610600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.675900E-02 |
| Normal_Weight-vs-Obese |
6.194200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.939590E-02 |
| Extreme_Weight-vs-Obese |
2.583800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.027200E-01 |
| Obese-vs-Extreme_Obese |
5.357500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.043900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.89820000010499E-08 |
| Normal-vs-Age(61-80Yrs) |
6.29189999999946E-05 |
| Normal-vs-Age(81-100Yrs) |
8.226200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.266100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.106100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.832000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.664400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.407800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.313000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.96694999999858E-05 |
| Normal-VS-Type2 PRCC |
2.975600E-04 |
| Normal-VS-KIRP CIMP |
3.484400E-03 |
| Normal-VS-Unclassified PRCC |
2.825800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.582100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.043900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.306010E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.519300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.377800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.098250E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.098760E-03 |
| Normal-vs-N1 |
7.61020000000778E-05 |
| Normal-vs-N2 |
1.200230E-01 |
| N0-vs-N1 |
7.554600E-04 |
| N0-vs-N2 |
1.807380E-01 |
| N1-vs-N2 |
2.911000E-01 |
|
|
